An Integrated, Comprehensive Approach Utilizing a Pain Management Specialist to Co-Manage Opioid Use in a Ryan White Program
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Living with substance use disorder can compromise prevention interventions, diagnosis of HIV, engagement and retention in care, and viral suppression. Clinical coordinators serve an essential, unduplicated role in the provision of medication-assisted therapy (MAT) in HIV primary care. This presentation will share lessons learned to support the replication of MAT programs, including the clinical coordinator role, within your setting.
Resource (Conference Presentation) updated 09/14/2023
Rapid initiation of antiretroviral therapy (ART) after diagnosis can increase the number of patients arriving for appointments, shorten time to viral suppression, and promote health equity. The presenters share key lessons learned through the implementation process at a large HIV clinic in the South with the theme of partnerships.
Resource (Conference Presentation) updated 09/14/2023
In December 2016 CrescentCare began linking individuals newly diagnosed with within 72-hours through the CrescentCare START Initiative. We compared linkage and viral suppression between those under and over 24 years old. We found similar successful outcomes for both age cohorts in our intervention.
Resource (Conference Presentation) updated 09/14/2023
Implementation of rapid antiretroviral therapy (ART) initiation is beset with clinical and process challenges. Three clinical providers will share their lessons learned from developing a program and delivering care in various care settings (pediatric, adult, and walk-in clinic).
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023
Rapid antiretroviral treatment (ART) initiation in the United States remained 'investigational' until the update in the Department of Health and Human Services guidelines (December 18, 2019). Centers for AIDS Research (CFARs) in D.C., the San Francisco Bay area, and Baltimore will share how they are working with their health departments and implementing partners, including Ryan White-funded clinics to address rapid ART implementation strategies.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023
Timely antiretroviral treatment (ART) initiation, linkage, and retention in care are critical keys for the optimal outcomes in patients with HIV infection. Implementing an open access process for medical, mental, and intensive case management care gives patients the ability to better achieve medication adherence and viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
North Carolina's HIV/STD/Viral Hepatitis Unit, along with Western North Carolina Community Health Services and Carolina Family Health Center -- two federally qualified health centers (FQHCs) -- has initiated a pilot rapid antiretroviral treatment (ART) program utilizing carryover funds and a streamlined HIV Medication Assistance Program application process. Preliminary data will be shared on the success of the pilot program.
Resource (Conference Presentation) updated 09/14/2023
This presentation will review findings and lessons learned after implementing a pilot rapid antiretroviral therapy (ART) initiation protocol into an existing federally qualified health center (FQHC) setting. Presenters will describe the processes used for rapid linkage, benefits eligibility assessment, and provider appointment with ART initiation.
Resource (Conference Presentation) updated 09/14/2023
An overview will be provided on the prevention of opioid use disorders in Ryan White clinics and AIDS service organizations. Information will be provided on how to launch the Take Back, Educate, and Inundate initiative to encourage the launch of innovative approaches to reducing opioid use and misuse with people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Using an innovative Stakeholder Real-Time Delphi approach, 805 stakeholders (e.g., people with HIV, HIV service organization staff, HIV planning council representatives) from across the United States interactively assessed the prevalence rate and individual-level negative impacts of five substance abuse disorders (SUDs), which were combined to estimate the population-level negative impact of each SUD.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
This peer-led workshop will include skill-building interactive sessions about two evidence-informed interventions that address opioid use disorders among people with HIV, Buprenorphine Treatment and Screening, Brief Intervention, and Referral to Treatment.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
Substance abuse, interpersonal violence, depression, and HIV are part of overlapping and intersecting epidemics which adversely affect the prognosis and intensify the burden of each. This session will review existing literature on this syndemic, lessons learned in initial implementation of a screening and linkage program, and implications for practice.
Resource (Conference Presentation) updated 09/14/2023
This workshop will present findings from three recently completed HRSA/HAB-sponsored studies that evaluated the impact of the RWHAP, specifically regarding its cost-effectiveness, models of clinical care, and factors associated with viral suppression.
Resource (Conference Presentation) updated 09/14/2023
This presentation will review how the Michigan Department of Health and Human Services Chronic Disease Division collaborated with the HIV/STI division and local AIDS service organizations to develop innovative, client-centered tobacco dependence treatment programs to address the high tobacco use rates among people with HIV.
Resource (Conference Presentation) updated 09/14/2023